Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
Berenson, J R, Hilger, J D, Yellin, O, Dichmann, R, Patel-Donnelly, D, Boccia, R V, Bessudo, A, Stampleman, L, Gravenor, D, Eshaghian, S, Nassir, Y, Swift, R A, Vescio, R A
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma
BERENSON, J. R, YELLIN, O, VESCIO, R, SWIFT, R. A, KAZAMEL, T, HILGER, J. D, CHEN, C.-S, CARTMELL, A, WOLIVER, T, FLAM, M, BRAVIN, E, NASSIR, Y
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists
Samanen, James M, Ali, Fadia E, Barton, Linda S, Bondinell, William E, Burgess, Joelle L, Callahan, James F, Calvo, Raul R, Chen, Wenting, Chen, Lichong, Erhard, Karl, Feuerstein, Giora, Heys, Richard, Hwang, Shing-Mei, Jakas, Dalia R, Keenan, Richard M, Ku, Thomas W, Kwon, Chet, Lee, Chao-Pin, Miller, William H, Newlander, Kenneth A, Nichols, Andrew, Parker, Michael, Peishoff, Catherine E, Rhodes, Gerald, Ross, Steven, Shu, Arthur, Simpson, Richard, Takata, Dennis, Yellin, Tobias O, Uzsinskas, Irene, Venslavsky, Joseph W, Yuan, Chuan-Kui, Huffman, William F
Published in Journal of medicinal chemistry (06.12.1996)
Published in Journal of medicinal chemistry (06.12.1996)
Get full text
Journal Article
Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation
Ali, Fadia E, Bennett, Donald B, Calvo, Raul R, Elliott, John D, Hwang, Shing-Mei, Ku, Thomas W, Lago, M. Amparo, Nichols, Andrew J, Romoff, Todd T
Published in Journal of medicinal chemistry (01.03.1994)
Published in Journal of medicinal chemistry (01.03.1994)
Get full text
Journal Article
Percutaneous Tube Drainage: The Treatment of Choice for Refractory Lung Abscess
Yellin, Alon, Yellin, Edwin O., Lieberman, Yair
Published in The Annals of thoracic surgery (01.03.1985)
Published in The Annals of thoracic surgery (01.03.1985)
Get full text
Journal Article
A phase I/II study of oral melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R/R) multiple myeloma (MM)
Kazamel, T., Berenson, J. R., Yellin, O., Boccia, R. V., Matous, J., Dressler, K. A., Nassir, Y., Rothstein, S., Swift, R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase II study of pegylated liposomal doxorubicin, bortezomib, dexamethasone, and lenalidomide (DVD-R) for patients with relapsed/refractory (R/R) multiple myeloma (MM)
Yellin, O., Berenson, J. R., Kazamel, T., Chen, C., Cartmel, A., Woliver, T. B. S., Flam, M. S., Bravin, E. N., Nassir, Y., Vescio, R. A., Swift, R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A retrospective review of pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone (DVD) for relapsed or refractory (R/R) multiple myeloma (MM)
Waterman, G. N., Yellin, O., Swift, R. A., Hilger, J., Berenson, J. R.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists
Samanen, James M., Lee, Chao-Pin, Smith, Philip L., Bondinell, William E., Calvo, Raul R., Jakas, Dalia R., Newlander, Kenneth A., Parker, Michael, Uzinskas, Irene, Yellin, Tobias O., Nichols, Andrew J.
Published in Advanced drug delivery reviews (15.01.1997)
Published in Advanced drug delivery reviews (15.01.1997)
Get full text
Journal Article
Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial
Berenson, J. R., Yellin, O., Bessudo, A., Boccia, R., Noga, S., Gravenor, D., Patel-Donnelly, D., Siegel, R. S., Kewalramani, T., Gorak, E. J., Swift, R., Bensen-Kennedy, D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib, and dexamethasone regimen for patients with previously untreated multiple myeloma (MM)
Berenson, J. R., Yellin, O., Chen, C., Patel, R., Bessudo, A., Boccia, R. V., Yang, H., Gupta, V., Hilger, J., Swift, R. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase II study of a 1-hour infusion of romidepsin combined with bortezomib for multiple myeloma (MM) patients with relapsed or refractory disease
Berenson, J. R., Yellin, O., Mapes, R., Eades, B., Abaya, C. D., Strayer, A., Nix, D., Swift, R. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Relationship between anti-diarrheal activity and binding to calmodulin
Zavecz, J H, Jackson, T E, Limp, G L, Yellin, T O
Published in European journal of pharmacology (12.03.1982)
Published in European journal of pharmacology (12.03.1982)
Get more information
Journal Article
Histamine receptors in the myenteric plexus-longitudinal muscle of the guinea-pig ileum: H1- and H2-receptor-mediated potentiation of the contractile response to electrical stimulation
Zavecz, J H, Yellin, T O
Published in The Journal of pharmacology and experimental therapeutics (01.10.1982)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.10.1982)
Journal Article
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid
Berenson, James R., Yellin, Ori, Crowley, John, Makary, Adel, Gravenor, Donald S., Yang, Hank H., Upadhyaya, Gargi H., Flinn, Ian W., Staszewski, Harry, Tiffany, Natasha M., Sanani, Shamel, Farber, Charles M., Morganstein, Neil, Bolejack, Vanessa, Nassir, Youram, Hilger, James D., Sefaradi, Ashkan, Shamouelian, Albert, Swift, Regina A.
Published in American journal of hematology (01.01.2011)
Published in American journal of hematology (01.01.2011)
Get full text
Journal Article
Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL)
Yellin, O., Crowley, J., Swift, R. A., Makary, A., Gravenor, D. S., Yang, H. H., Upadhyaya, G. H., Flinn, I. W., Staszewski, H., Tiffany, N. M., Berenson, J. R.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Marked improvement in bone mineral density (BMD) for patients (pts) with monoclonal gammopathy of undetermined significance (MGUS) using zoledronic acid (ZOL)
Berenson, J. R., Yellin, O., Boccia, R. V., Flam, M. S., Wong, S., Batuman, O., Moezi, M. M., Woytowitz, D. V., Duvivier, H. L., Nassir, Y., Swift, R.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article